Cedars-Sinai Newsroom (Alzheimers)
Filter by year
2024
February
28,
2024
|
06:30 AM
America/Los_Angeles
Mitzi Gonzales, PhD, a board-certified neuropsychologist, has joined Cedars-Sinai as director of Translational Research in the Jona Goldrich Center for Alzheimer’s and Memory Disorders in the Department of Neurology at Cedars-Sinai. She will treat …
Read more
January
11,
2024
|
06:30 AM
America/Los_Angeles
Cedars-Sinai investigators are using electronic health records to identify hospitalized patients likely to have dementia. The method they developed, detailed in a study published in the peer-reviewed Journal of the American Geriatrics Society, is …
Read more
2023
August
22,
2023
|
06:00 AM
America/Los_Angeles
In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market. The test, which has not undergone Food and Drug Administration (FDA) review, measures the level of a protein called …
Read more
July
06,
2023
|
07:01 AM
America/Los_Angeles
Cedars-Sinai patient care teams are preparing to offer lecanemab, a new Alzheimer’s disease treatment that has received approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months. “This is the most promising …
Read more